Surface Plasmon Resonance Market Expected to Reach USD 1.99 Billion by 2032 | Growing at a CAGR of 6.80%

Market Research Future (MRFR) has published a cooked research report on the “Global Surface Plasmon Resonance Market” that contains information from 2018 to 2032. The surface plasmon resonance market is estimated to register a CAGR of 6.80% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global surface plasmon resonance market— are GE Healthcare, AMETEK.Inc., Horiba, Bio-Rad Laboratories, Inc., Carterra Inc., Bristol Myers Squibb, Bruker, Biosensing Instrument Inc., Malvern Panalytical, and Reichert Technologies.

Market Highlights

The global surface plasmon resonance market is accounted to register a CAGR of 6.80% during the forecast period and is estimated to reach USD 1.99 billion by 2032.

The surface plasmon resonance market is propelled by increasing demand for label-free detection methods in drug discovery and development, driven by the need for real-time monitoring and analysis of bimolecular interactions. The advancements in SPR technology, such as improved sensitivity and multiplexing capabilities, further stimulate market growth by expanding its applicability across various research fields. Moreover, the rising adoption of personalized medicine and targeted therapies amplifies the demand for SPR systems, as they offer precise and reliable solutions for molecular profiling and diagnostics, consolidating their position as indispensable tools in biomedical research and clinical applications.

Segment Analysis

The global surface plasmon resonance market has been segmented based on product type, application type, and end user.

On the basis of product type, the market is segmented into imaging system, sensor system, and reagents. The imaging system segment was attributed to holding the largest market share in 2022. the growing need for real-time molecular interaction visualisation, which boosts research productivity and speeds up drug discovery procedures. Further driving usage are improvements in sensitivity and resolution provided by imaging technology breakthroughs.

Based on application type, the global surface plasmon resonance market has been segmented into drug discovery, material science, and biosensors. The drug discovery segment was expected to hold the largest market share in 2022. The growing need for quick, precise bimolecular interaction studies in order to identify and optimise promising therapy candidates as soon as possible. Furthermore, the adaptability and effectiveness of SPR technology become more and more crucial as pharmaceutical businesses step up their attempts to create novel medicines, propelling market expansion.

Based on end user, the global surface plasmon resonance market has been segmented into academic & research institutes, food & beverage industry, biopharmaceutical companies, CROs, and others. The biopharmaceutical companies segment was expected to hold the largest market share in 2022. Due to the crucial role that SPR technology plays in accelerating drug development processes, improving research efficiency, and guaranteeing the quality of therapeutic candidates, sales are expected to rise.

Regional Analysis

The global surface plasmon resonance market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe surface plasmon resonance market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The surface plasmon resonance market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World surface plasmon resonance market comprises of Middle East, Africa, and Latin America.

In North America, the sales of surface plasmon resonance systems are poised to increase due to robust investment in pharmaceutical research and development, driven by stringent regulatory standards and a dynamic biotechnology landscape. Additionally, the region's strong presence of academic and research institutes fosters innovation and drives demand for advanced analytical tools like SPR, while the increasing focus on precision medicine further amplifies the adoption of SPR technology for personalized diagnostics and therapeutics.

Sales of surface plasmon resonance systems in Europe are anticipated to rise owing to the region's emphasis on translational research and collaborative partnerships between academia and industry. Furthermore, stringent regulatory frameworks promote the adoption of innovative technologies for drug discovery and development, driving demand for SPR systems with enhanced sensitivity and throughput. Additionally, the growing prevalence of chronic diseases fuels the need for advanced diagnostic solutions, further boosting the market for SPR technology in Europe.

In the Asia Pacific region, the sales of surface plasmon resonance systems are set to surge due to rapid industrialization, increasing investment in healthcare infrastructure, and growing awareness about personalized medicine. Additionally, government initiatives aimed at fostering innovation and supporting biotechnology research drive the adoption of advanced analytical instruments like SPR for drug discovery and biomedical applications. Moreover, the region's expanding pharmaceutical industry and rising healthcare expenditure further fuel market growth for SPR technology.

In the Rest of the World region, the sales of surface plasmon resonance systems are expected to increase as emerging economies prioritize healthcare infrastructure development and invest in cutting-edge biomedical research. Furthermore, the growing prevalence of infectious diseases and the need for rapid diagnostics propel the demand for SPR technology in clinical settings. Additionally, the rising adoption of precision medicine and the expansion of biopharmaceutical manufacturing facilities contribute to the growth of the SPR market in this region.

Key Findings of the Study

• The global surface plasmon resonance market is expected to reach USD 1.99 billion by 2032, at a CAGR of 6.80% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market due to expansion of life sciences research, particularly in fields such as proteomics, genomics, and immunology.


• Based on product type, the imaging system segment was attributed to holding the largest market in 2022, with an approximate market share of 45%–50%.


• GE Healthcare, AMETEK.Inc., Horiba, Bio-Rad Laboratories, Inc., Carterra Inc., Bristol Myers Squibb, Bruker, Biosensing Instrument Inc., Malvern Panalytical, and Reichert Technologies.